Diurnal Variation in Fasting Plasma Glucose
نویسندگان
چکیده
منابع مشابه
Diurnal variation in glucose tolerance and its reversal by lengthened fasting.
In a group of healthy young male volunteers a worsened tolerance to oral glucose in the afternoon after a four-hour fast was reversed by a 12-hour fast. The latter also produced consistent mild hypoglycaemia from two and a half to four hours after the glucose loading irrespective of the time of day.
متن کاملDiurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening.
Twenty-four subjects received three oral glucose tolerance tests, in the morning, afternoon, and evening of separate days. The mean blood sugar levels in the afternoon and evening tests were similar, and they were both significantly higher than those in the morning test. Plasma immunoreactive insulin levels, however, were highest in the morning test. The pattern of insulin levels during the aft...
متن کاملA New Method to Evaluate Fasting Plasma Glucose by Salivary Glucose Measurement
Objective:Fasting plasma glucose (FPG) analysis is the most importantmethod for detection and diagnosis of diabetes mellitus. Due to difficulty and problems of this method for determination of glycemia in diabetic patients, recently the use of Fasting Salivary Glucoseas a simple and non-invasive method to evaluate FPGhas came into significant considerationof specialists. The aim of this study w...
متن کاملGreater variation in affect is associated with lower fasting plasma glucose#
BACKGROUND Depression and bipolar illness are associated with a 2-3 fold increase in the prevalence of diabetes. However, it is unknown whether variation in mood affects glucose metabolism. The aim of this study was to assess whether changes in affect were related to fasting plasma glucose and glycated haemoglobin. METHODS 379 men and 441 women who took part in the 2003 Health Survey for Engl...
متن کاملCommon variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations
AIM Inhibition of sodium/glucose cotransporter 2 (SGLT2), the key transport protein in renal glucose reabsorption, promotes glucose excretion and represents a new concept in the therapy of type-2 diabetes. In addition, SGLT2 inhibition elevates circulating glucagon concentrations and enhances hepatic glucose production. Since SGLT2 is expressed in human pancreatic α-cells and regulates glucagon...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA
سال: 2000
ISSN: 0098-7484
DOI: 10.1001/jama.284.24.3157